India’s aneurysm coiling and embolization devices market is poised for significant growth, projected to expand at a CAGR of 7.8% during 2024–2031. Fueled by rising incidences of brain aneurysms, increased access to minimally invasive neurovascular procedures, and global technology transfer from the U.S. and Japan, the market is entering a dynamic phase.

Major Indian cities like Delhi, Mumbai, Bengaluru, and Hyderabad are seeing strong procedural uptakes, led by private multispecialty hospitals and neurointervention units. Simultaneously, AI-based imaging diagnostics, robotic catheterization, and low-profile detachable coils are reshaping care delivery.

Get Sample report here:

https://www.datamintelligence.com/download-sample/india-aneurysm-coiling-and-embolization-devices-market

Market Drivers

1. Growing Burden of Cerebral Aneurysms & Stroke

India reports an alarming 1.5 million stroke cases annually, with ruptured cerebral aneurysms accounting for a major chunk. Aneurysm coiling offers a less risky, faster-recovery alternative to open neurosurgery.

2. Rising Adoption of Minimally Invasive Interventions

Neurointerventional radiology is increasingly preferred due to shorter hospital stays, reduced complications, and precision targeting using detachable platinum coils, flow diverters, and embolic agents.

3. Technological Transfer from U.S. & Japan

Leading neurovascular companies like Medtronic, Stryker, Penumbra, and MicroVention Terumo are expanding their portfolios in India. Their U.S. FDA- and PMDA-cleared technologies are setting new benchmarks in performance and safety.

4. Growing Neurovascular Infrastructure in India

Tier-1 and Tier-2 cities are witnessing improved access to digital subtraction angiography (DSA), 3D rotational imaging, and hybrid operating rooms, enabling adoption of coiling and embolization techniques even outside metros.

5. Government Support through Health Schemes

India’s flagship schemes like Ayushman Bharat (PMJAY) are enabling wider affordability of high-end procedures, including neuroendovascular treatments, in semi-urban and rural belts.

Regional and Global Insights

India

Urban hospitals report rising usage of coiling and embolization for unruptured aneurysms, with younger patients increasingly opting for early detection and treatment. The launch of domestically manufactured coils and microcatheters is further boosting affordability.

United States

The U.S. remains the innovation hub for neurovascular solutions. The development of next-gen embolic coils with shape memory alloy cores, liquid embolics (Onyx, PHIL), and biodegradable embolization agents is influencing Indian practice standards through partnerships and imports.

Japan

Japan’s long-standing expertise in microcatheter navigation, coiling precision, and device miniaturization is positively impacting Indian procedural protocols. Companies like Terumo Corporation have a growing presence in India with tailored training and device support.

Key Product Segments in Demand

Major Hospitals Leading the Charge

• All India Institute of Medical Sciences (AIIMS), New Delhi
• Apollo Hospitals, Chennai & Hyderabad
• Fortis Escorts, Delhi
• KIMS Hospitals, Hyderabad
• NIMHANS, Bengaluru

These centers have invested in neurointervention units, skilled interventional radiologists, and multimodality imaging—making them referral hubs for aneurysm care.

Key Market Players

• Stryker Corporation
• Medtronic Plc
• MicroVention Terumo
• Penumbra Inc.
• Balt Extrusion
• Phenox GmbH
• InNeuroCo
• Indian MedTech start-ups (emerging in catheter and coil production)

These companies are actively involved in training programs, device customization, and collaborative research to improve localized care outcomes.

Growth Opportunities

• AI and ML in Neuro Imaging: Enhances aneurysm detection, helps plan coiling strategy, and predicts rupture risk.
• Customized Coiling Kits: Device bundling for Indian procedures helps in cost optimization and procedure standardization.
• Local Device Manufacturing: ‘Make in India’ initiatives support cost-effective, India-specific coil and catheter development.
• Public–Private Partnerships (PPP): Hospitals, device companies, and the government co-invest in capacity-building for neurointerventions.

Emerging Trends in U.S. & Japan

U.S.:

• Growing use of robotic-assisted catheterization.
• Research on bioactive embolics that promote vascular healing.
• Expansion of ambulatory neurointervention centers.

Japan:

• Development of hybrid neurointervention suites combining MRI and cath lab.
• Focus on zero-fluoroscopy navigation systems.
• Surge in geriatric aneurysm management using ultra-soft coils.

Buy this full report here:

https://www.datamintelligence.com/buy-now-page?report=india-aneurysm-coiling-and-embolization-devices-market

Conclusion

The India Aneurysm Coiling and Embolization Devices Market is evolving rapidly, backed by innovation, clinical need, and health policy reforms. With international technology partnerships, robust medical infrastructure, and trained specialists, India is well-positioned to scale up access to life-saving neurovascular treatments.

As procedural awareness increases and cost barriers are lowered, India’s coiling device market is expected to transform the neurocare landscape, offering hope and healing to thousands affected by brain aneurysms.